The relationship between FDG uptake in PET scans and biological behavior in breast cancer

References

Page 1

	Year	Citations
Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Richard L. Wahl, Robert L. Cody, Gary D. Hutchins, Radiology Positron Emission TomographyFdg UptakeBreast OncologyOncologic ImagingMedical Imaging	1991	433
The general rules for clinical and pathological recording of breast cancer Surgery Today General RulesBreast OncologyMedical ImagingCancer DetectionMedicine	1989	377
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Lee P. Adler, Joseph P. Crowe, Nadia Al‐Kaisi, Radiology Positron Emission TomographyBreast OncologyBreast MassesMedical ImagingMedicine	1993	374
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. Kotaro Higashi, Anaira C. Clavo, Richard L. Wahl PubMed PathologyCell ProliferationMeasure Proliferative ActivityDoes FdgCancer Biology	1993	313
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. Farrokh Dehdashti, Joanne Mortimer, Siegel Ba, PubMed	1995	291
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Andrew L. Folpe, Robert H. Lyles, Jason T. Sprouse, PubMed Surgical OncologyOncologic ImagingPet-mriPathologyPathologic Grade	2000	261
Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. Norbert Avril, J. Dose, F. Jänicke, Journal of Clinical Oncology	1996	241
Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer Omgo E. Nieweg, E. Edmund Kim, Wai‐Hoi Wong, Cancer	1993	224
Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose Norbert Avril, J. Dose, F. Jänicke, JNCI Journal of the National Cancer Institute	1996	215
Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Harish Kumar, K Heer, Peter W. R. Lee, PubMed Surgical OncologyImmunologyPathologyPreoperative Serum VegfCancer Biology	1998	190

Page 1